×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio
Logo

Insider Transactions by Joseph P. Lyssikatos


Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERFeb 06, 2026Sale$29.045,000145,219740,188Feb 10, 2026, 06:12 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERJan 20, 2026Sale$26.7520,000535,099759,697Jan 22, 2026, 05:34 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERJan 09, 2026Sale$27.2291,1982,482,578815,188Jan 12, 2026, 05:12 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERJan 08, 2026Sale$24.0541,302993,436890,188Jan 12, 2026, 05:12 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERDec 19, 2025Sale$16.845,00084,206897,688Dec 23, 2025, 06:45 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERNov 19, 2025Sale$22.3312,500279,155903,180Nov 21, 2025, 05:28 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICEROct 20, 2025Sale$22.0812,500276,025915,188Oct 22, 2025, 07:20 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERSep 26, 2025Sale$20.254,00081,005927,688Sep 30, 2025, 05:53 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERSep 23, 2025Sale$20.031,50030,045931,688Sep 25, 2025, 07:44 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERSep 19, 2025Sale$19.397,000135,697935,318Sep 23, 2025, 05:14 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERAug 19, 2025Sale$19.625,00098,118947,688Aug 21, 2025, 06:46 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERAug 21, 2025Sale$20.017,500150,099940,188Aug 21, 2025, 06:46 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERJul 21, 2025Sale$22.2912,500278,646953,264Jul 23, 2025, 06:52 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERJun 20, 2025Sale$21.4012,500267,458965,188Jun 24, 2025, 05:36 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERJun 03, 2025Sale$20.037,500150,220977,688Jun 05, 2025, 04:55 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERMay 19, 2025Sale$16.315,00081,533985,188May 21, 2025, 06:31 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERMay 01, 2025Sale$20.075,030100,966992,658May 05, 2025, 06:43 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERMay 02, 2025Sale$20.012,47049,424990,188May 05, 2025, 06:43 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERApr 21, 2025Sale$16.075,00080,366998,018Apr 23, 2025, 05:09 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERMar 19, 2025Sale$20.6112,500257,5751,002,688Mar 21, 2025, 05:49 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICEROct 18, 2024Sale$30.0084725,4131,015,188Oct 22, 2024, 04:22 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICEROct 08, 2024Sale$27.9713,267371,0241,054,013Oct 10, 2024, 08:39 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICEROct 09, 2024Sale$28.1637,8781,066,5611,019,624Oct 10, 2024, 08:39 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICEROct 04, 2024Sale$27.517,522206,9371,069,887Oct 08, 2024, 06:58 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICEROct 07, 2024Sale$27.612,70774,7271,067,180Oct 08, 2024, 06:58 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICEROct 01, 2024Sale$27.5452714,5121,077,409Oct 03, 2024, 06:47 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERAug 29, 2024Sale$22.4912,000269,8411,077,986Sep 03, 2024, 05:43 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERJul 31, 2024Sale$27.563,09985,3991,089,936Aug 02, 2024, 07:26 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERJul 29, 2024Sale$26.7012,000320,3781,093,238Jul 31, 2024, 07:33 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERJul 01, 2024Sale$22.8912,000274,7361,105,035Jul 03, 2024, 04:31 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERMay 29, 2024Option/RSU Exercise$1.1212,00013,44012,000May 31, 2024, 04:05 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERMay 29, 2024Sale$21.7312,000260,8002,123May 31, 2024, 04:05 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERApr 29, 2024Option/RSU Exercise$1.1212,00013,44012,000May 01, 2024, 07:04 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERApr 29, 2024Sale$17.9212,000214,9881,013May 01, 2024, 07:04 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERApr 11, 2024Option/RSU Exercise$1.1230,00033,60030,000Apr 15, 2024, 07:06 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERApr 11, 2024Sale$25.0430,000751,3320Apr 15, 2024, 07:06 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERApr 01, 2024Option/RSU Exercise$1.1212,00013,44012,000Apr 03, 2024, 09:30 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERApr 01, 2024Sale$18.6012,000223,1469,648Apr 03, 2024, 09:30 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERFeb 29, 2024Sale$16.4212,000197,0061,805Mar 04, 2024, 05:55 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERFeb 29, 2024Option/RSU Exercise$1.1212,00013,44012,000Mar 04, 2024, 05:55 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERJan 29, 2024Option/RSU Exercise$1.1212,00013,44012,000Jan 31, 2024, 09:22 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosCHIEF SCIENTIFIC OFFICERJan 29, 2024Sale$15.8512,000190,2560Jan 31, 2024, 09:22 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosChief Scientific OfficerDec 29, 2023Option/RSU Exercise$1.1212,00013,44012,000Jan 03, 2024, 07:01 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosChief Scientific OfficerDec 29, 2023Sale$14.2812,000171,3812,849Jan 03, 2024, 07:01 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosChief Scientific OfficerDec 22, 2023Sale$13.076,54685,5300Dec 26, 2023, 07:32 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosChief Scientific OfficerDec 21, 2023Option/RSU Exercise$1.12202220Dec 26, 2023, 07:32 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosChief Scientific OfficerDec 21, 2023Sale$13.00202600Dec 26, 2023, 07:32 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosChief Scientific OfficerDec 22, 2023Option/RSU Exercise$1.126,5467,3326,546Dec 26, 2023, 07:32 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosChief Scientific OfficerDec 20, 2023Option/RSU Exercise$1.128,6889,7318,688Dec 21, 2023, 04:29 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosChief Scientific OfficerDec 20, 2023Sale$13.018,688113,0460Dec 21, 2023, 04:29 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosChief Scientific OfficerDec 19, 2023Option/RSU Exercise$1.12200224200Dec 21, 2023, 04:29 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosChief Scientific OfficerDec 19, 2023Sale$13.002002,6000Dec 21, 2023, 04:29 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosChief Scientific OfficerNov 03, 2023Option/RSU Exercise$1.128,5469,5728,546Nov 06, 2023, 04:43 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosChief Scientific OfficerNov 03, 2023Sale$13.088,546111,7510Nov 06, 2023, 04:43 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosChief Scientific OfficerSep 29, 2023Sale$13.6212,000163,4980Oct 03, 2023, 07:40 PM
ELVNEnliven Therapeutics, Inc.Joseph P. LyssikatosChief Scientific OfficerSep 29, 2023Option/RSU Exercise$1.1212,00013,44012,000Oct 03, 2023, 07:40 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe